Home

chapter wheel Perforation kras colon cancer end point leather Regan

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research

The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library

Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options

APMG Colon Molecular Pathways
APMG Colon Molecular Pathways

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT

Colorectal Cancer
Colorectal Cancer

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM

KRAS Positive Lung Cancer: Testing and Management
KRAS Positive Lung Cancer: Testing and Management

Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine

The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect

KRAS Biomarker | Colorectal Cancer Alliance
KRAS Biomarker | Colorectal Cancer Alliance

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports

IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?

Full article: Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients
Full article: Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology

Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications

Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers

IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer

Mapping the KRAS Proteoform in Colorectal Cancer - MagLab
Mapping the KRAS Proteoform in Colorectal Cancer - MagLab

Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers

Progress towards individualized treatment of colorectal cancer UAB Barcelona
Progress towards individualized treatment of colorectal cancer UAB Barcelona

VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab | 2 Minute Medicine
VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab | 2 Minute Medicine

Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram

Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar